Visceral fat index may indicate a patient’s risk for refractory inflammatory bowel disease and likelihood of surgery, suggesting early surgical referral in these cases, according to a presentation at the Crohn’s and Colitis Congress.

“Patients with a higher [visceral fat index] were profoundly more likely to undergo surgery within 6 and 12 months with the majority of patients needing to undergo surgery within 6 months of starting their anti-TNF,” Phillip Gu, MD, a fellow at UT Southwestern Medical Center, said in his presentation.

Gu and colleagues looked at patients

Full Article: